Adjunctive therapies in nutritional support.
The need for new therapeutic approaches to improve the metabolic and clinical efficacy of nutritional therapy has been increasingly emphasized. The field of nutrition support of catabolic, malnourished, or hospitalized patients is rapidly evolving in response to the beneficial effects observed with adjunctive therapies in animal models and in emerging clinical investigations. Enteral nutrition is being increasingly administered, and enteral diets are being tested to improve gut structure and function. Adjunctive therapies in enteral and parenteral nutrition are being actively investigated. These include administration of recombinant growth factors and anabolic steroid hormones (e.g., growth hormone, oxandrolone); conditionally essential amino acids (e.g., arginine, glutamine); novel lipid products (e.g., structured lipids, fish oils); nutrient antioxidants (e.g., vitamins C and E); and combinations of these approaches. It is likely that current methods of enteral and parenteral nutrition support will evolve in response to the results of these research studies.
Ziegler
T R
TR
Department of Medicine, Emory University Hospital, Emory University School of Medicine, Atlanta, Georgia, USA.
Leader
L M
LM
Jonas
C R
CR
Griffith
D P
DP
D000601:Amino Acids, Essential / Q000008:administration & dosage / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D000818:Animals; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D018529:Nutritional Support; D011994:Recombinant Proteins / Q000627:therapeutic use; D013812:Therapeutics
D000601:Amino Acids, Essential; D045930:Anabolic Agents; D006133:Growth Substances; D011994:Recombinant Proteins